Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Building better beta cells.

Edouard G Stanley1, Andrew G Elefanty

  • 1Monash Immunology and Stem Cell Laboratories, Level 3, Building 75, STRIP 1, West Ring Road, Monash University, Clayton, Victoria 3800, Australia. ed.stanley@med.monash.edu.au

Cell Stem Cell
|April 10, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of spatial transcriptomics across organoids for a high-resolution, spatial whole-transcriptome benchmarking dataset.

iScience·2026
Same author

Macrophages orchestrate antiviral defense and epithelial repair in a human iPSC-derived alveolar air-liquid interface.

JCI insight·2026
Same author

LY6H is a marker of human pancreatic delta cells.

Scientific reports·2025
Same author

Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis.

Nature communications·2024
Same author

Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cells.

Nature biotechnology·2024
Same author

Liver specification of human iPSC-derived endothelial cells transplanted into mouse liver.

JHEP reports : innovation in hepatology·2024
Same journal

Psychological stress drives aging-like hematopoietic stem cell dysfunction through a brain-gut-bone marrow axis.

Cell stem cell·2026
Same journal

Human stem cell-based embryo model governance: Insights from Japan.

Cell stem cell·2026
Same journal

From reconstruction to intervention: Engineered organoids as living therapeutic depots.

Cell stem cell·2026
Same journal

Long-term lessons from MATCH01 macrophage therapy in cirrhosis.

Cell stem cell·2026
Same journal

Beyond apoptosis: LSC state dictates metabolic and anti-apoptotic vulnerabilities.

Cell stem cell·2026
Same journal

Outside the niche: Gut microbiota relay psychological stress to hematopoietic stem cell dysfunction.

Cell stem cell·2026
See all related articles

Human embryonic stem cells show promise for type 1 diabetes treatment. Researchers developed functional islet-like structures from stem cells, offering hope for cell replacement therapy.

Area of Science:

  • Biomedical research
  • Stem cell biology
  • Endocrinology

Background:

  • Type 1 diabetes is a significant health concern.
  • Human embryonic stem cells (hESCs) offer potential for regenerative medicine.
  • Cell replacement therapy is a promising avenue for treating type 1 diabetes.

Discussion:

  • Kroon et al. (2008) reported advancements in hESC-based therapies.
  • Development of functional islet-like structures is crucial for therapeutic success.
  • Transplantation in mice demonstrated the potential of hESC-derived cells.

Key Insights:

  • hESC-derived pancreatic endoderm can form functional islet-like structures.
  • These structures exhibit potential for successful transplantation in vivo.

Related Experiment Videos

  • This research marks significant progress in stem cell-based diabetes treatment.

    • Outlook:

    • Further research is needed to optimize hESC differentiation protocols.
    • Clinical translation requires rigorous safety and efficacy evaluations.
    • This work paves the way for future type 1 diabetes cell therapies.